MRA Advisory Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,581
Closed -$551K 179
2026
Q1
$551K Buy
8,581
+2,144
+33% +$196K 0.22% 66
2025
Q4
$837K Sell
6,437
-989
-13% -$136K 0.35% 46
2025
Q3
$800K Buy
7,426
+4,197
+130% +$457K 0.35% 42
2025
Q2
$298K Buy
+3,229
New +$253K 0.14% 101

Other funds holding WGS

MRA Advisory Group's WGS Position: Q2 2026 in Review

MRA Advisory Group sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 8,581 shares — an estimated $551K sold.

MRA Advisory Group first reported a position in WGS in Q2 2025 and held it in 4 quarters. The position peaked at $837K in Q4 2025. 25 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • MRA Advisory Group reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • MRA Advisory Group sold 8,581 GeneDx Holdings shares in Q2 2026, an estimated $551K.
  • MRA Advisory Group first reported a position in GeneDx Holdings in Q2 2025 and held it in 4 quarters.
  • MRA Advisory Group's GeneDx Holdings position peaked at $837K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on MRA Advisory Group's 13F filing for Q2 2026, filed 8 Jul 2026.